Abstract:AIM:To establish a mice model of hepatitis B by using HBV-transgenic mice, and to transfer HBV-specific cytotoxic T lymphocytes (CTL) induced from syngeneic BALB/c mice immunized by a eukaryotic expression vector containing HBV complete genome DNA.METHODS:HBV DNA was obtained from digested pBR322-2HBV and ligated with the vector pcDNA3. Recombinant pcDNA3-HBV was identified by restriction endonuclease assay and transfected into human hepatoma cell line HepG2 with lipofectin. ELISA was used to detect the expression of HBsAg in culture supernatant, and RT-PCR to determine the existence of HBV PreS1 mRNA. BALB/c mice were immunized with pcDNA3-HBV or pcDNA3 by intramuscular injection. ELISA was used to detect the expression of HBsAb in serum. MTT assay was used to measure non-specific or specific proliferation ability and specific killing activity of spleen lymphocytes. Lymphocytes from immunized mice were transferred into HBV-transgenic mice (2.5X10(7) per mouse). Forty-eight hours later, the level of serum protein and transaminase was detected with biochemical method, liver and kidney were sectioned and stained by HE to observe the pathological changes.RESULTS:By enzyme digestion with Eco RI, Xho I and Hind III, the recombinant pcDNA3-HBV was verified to contain a single copy of HBV genome, which was inserted in the positive direction. HepG2 cells transfected with the recombinant could stably express PreS1 mRNA and HBsAg. After immunized by pcDNA3-HBV for 4 weeks, HBsAb was detected in the serum of BALB/c mice. The potential of spleen lymphocytes for both non-specific and specific proliferation and the specific killing activity against target cells were enhanced. The transgenic mice in model group had no significant changes in the level of serum protein but had an obvious increase of ALT and AST. The liver had obvious pathological changes, while the kidney had no evident damage.CONCLUSION:A eukaryotic expression vector pcDNA3-HBV containing HBV complete genome is constructed successfully. HepG2 cells transfected with the recombinant can express PreS1 mRNA and HBsAg stably. Specific cellular immune response can be induced in mice immunized by pcDNA3-HBV. A mice model of acute hepatitis with HBV has been established.

Differential Regulation of Host Genes Including Hepatic Fatty Acid Synthase in HBV-transgenic Mice.

Inhibition of Hepatitis B Virus Gene Expression and Replication by Hepatocyte Nuclear Factor 6

Metabolic Regulation of Hepatitis B Virus Infection in HBV-Transgenic Mice

Expression of Hepatitis B Virus Proteins in Transgenic Mice Alters Lipid Metabolism and Induces Oxidative Stress in the Liver.

Hepatocytes Proteomic Alteration and Seroproteome Analysis of HBV‐transgenic Mice

Transcriptomic and Proteomic Study of HBsAg Positive Transgenic Mouse Liver Suggests That Viral Protein Affects the Hepatocellular Metabolism of Sugar, Lipid and Amino Acids

Toll-like Receptor Dependent Innate Immune Responses by Primary Mouse Hepatocytes and Its Control of HBV Replication

Proteomic Analysis of Hepatitis B Surface Antigen Positive Transgenic Mouse Liver and Decrease of Cyclophilin A

Proteomic analysis of cellular protein alterations using a hepatitis B virus-producing cellular model

Differentially Expressed Intrahepatic Genes Contribute to Control of Hepatitis B Virus Replication in the Inactive Carrier Phase

Interferon-α modulates HBV specific T-cell response to inhibit viral gene expression in chronic HBV infection mouse model

Gene Expression Profiles in an Hepatitis B Virus Transfected Hepatoblastoma Cell Line and Differentially Regulated Gene Expression by Interferon-Alpha

Fatty Liver Reduces Hepatitis B Virus Replication in a Genotype B Hepatitis B Virus Transgenic Mice Model

Different Antiviral Effects of IFNα and IFNβ in an HBV Mouse Model.

Bioinformatics Analysis on Multiple Gene Expression Omnibus Datasets of the Hepatitis B Virus Infection and Its Response to the Interferon-Alpha Therapy

Establishment of Mice Model with Human Viral Hepatitis B

The Study on the Relationship Between Expression of B7-H1 on HBV Transgenic Mice and Immune Toler-Ance to HBV

Saturated Fatty Acid Inhibits Viral Replication in Chronic Hepatitis B Virus Infection With Nonalcoholic Fatty Liver Disease by Toll-Like Receptor 4-Mediated Innate Immune Response

Transcriptional Analysis of Immune-Related Genes in Dendritic Cells from Hepatitis B Surface Antigen (Hbsag)-Positive Transgenic Mice and Regulation of Fc Gamma Receptor IIB by HBsAg-anti-HBs Complex.

The efficacy of zinc finger antiviral protein against hepatitis B virus transcription and replication in tansgenic mouse model

An HBV-tolerant immunocompetent model that effectively simulates chronic hepatitis B virus infection in mice.